Literature DB >> 7646162

Porcine valve durability: a comparison between Hancock standard and Hancock II bioprostheses.

U Bortolotti1, A Milano, E Mossuto, E Mazzaro, G Thiene, D Casarotto.   

Abstract

Two series of patients who received a Hancock standard (HS) (1970 to 1983) and a Hancock II (HII) (1983 to 1992) porcine bioprosthesis were reviewed to compare bioprosthetic durability. Patients with HS porcine bioprostheses (n = 769) differed from those with HII bioprostheses mostly in mean age at operation (47 +/- 12 versus 62 +/- 9 years; p < 0.001); the latter prosthesis was implanted mostly in patients older than 50 years. At 8 years after operation, actuarial survival was 57% +/- 4% after aortic, 61% +/- 3% after mitral, and 39% +/- 7% after mitral-aortic valve replacement with the HS bioprosthesis; actuarial survival was 51% +/- 9% after aortic, 66% +/- 6% after mitral, and 49% +/- 10% after mitral and aortic valve replacement with an HII bioprosthesis. No cases of structural deterioration of HII bioprostheses were observed at 8 years in any patients. Actuarial freedom from structural valve deterioration was 78% +/- 4% after aortic, 88% +/- 3% after mitral, and 79% +/- 7% after mitral-aortic valve replacement with an HS bioprosthesis at 8 years. In all patients greater than 50 years of age, actuarial freedom from structural valve deterioration at 8 years was 90% +/- 3% in patients with an HS bioprosthesis and 100% in those with an HII bioprosthesis (p = 0.08). A trend to an improved durability of the HII bioprosthesis compared with the HS was observed during the first 8 postoperative years. Because these results could be influenced partly by the age difference in the two series of patients, a longer follow-up is needed to confirm these data.

Entities:  

Mesh:

Year:  1995        PMID: 7646162     DOI: 10.1016/0003-4975(95)00255-j

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

Review 1.  Heart valve surgery today: indications, operative technique, and selected aspects of postoperative care in acquired valvular heart disease.

Authors:  Hans Joachim Geissler; Christian Schlensak; Michael Südkamp; Friedhelm Beyersdorf
Journal:  Dtsch Arztebl Int       Date:  2009-03-27       Impact factor: 5.594

2.  Hemodynamic performance of the Edwards Prima Plus stentless valve at 1 year.

Authors:  Keizo Tanaka; Toshihiko Kinoshita; Kazuya Fujinaga; Shinji Kanemitsu; Jin Tanaka; Hitoshi Suzuki; Toshiya Tokui
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-09-13

Review 3.  Artificial valves "up to date" in Japan.

Authors:  Shigehiko Tokunaga; Ryuji Tominaga
Journal:  J Artif Organs       Date:  2010-06-17       Impact factor: 1.731

4.  Mid- to Long-term Clinical Outcomes of Hancock II Bioprosthesis in Chinese Population.

Authors:  Yin Wang; Si Chen; Xing-Jian Hu; Jia-Wei Shi; Nian-Guo Dong
Journal:  Chin Med J (Engl)       Date:  2015-12-20       Impact factor: 2.628

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.